Ketamine's Antidepressant Actions: Potential Mechanisms in the Primate Medial Prefrontal Circuits That Represent Aversive Experience

Biol Psychiatry. 2016 May 1;79(9):713-5. doi: 10.1016/j.biopsych.2016.02.014.

Authors

Amy F T Arnsten¹, John D Murray², Hyojung Seo³, Daeyeol Lee³

Affiliations

¹ Departments of Neuroscience (AFTA, HS, DL), Yale University School of Medicine, New Haven, Connecticut; Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Electronic address: amy.arnsten@yale.edu.
² Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
³ Departments of Neuroscience (AFTA, HS, DL), Yale University School of Medicine, New Haven, Connecticut.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Animals
Antidepressive Agents / therapeutic use*
Humans
Ketamine / therapeutic use*
Primates

Substances

Antidepressive Agents
Ketamine

Grants and funding

DP1 AG047744/AG/NIA NIH HHS/United States